You are using an older browser version. Please use a supported version for the best MSN experience.

Covaxin works against most variants; CARE cuts India's GDP forecast

Bharat Biotech's COVID-19 vaccine has shown an overall interim clinical efficacy of 78 per cent and 100 per cent efficacy against severe COVID-19 disease; Putting tremendous pressure on the nation's medical infrastructure, the latest surge in COVID-19 cases has driven up the demand for medical oxygen, a critical commodity in treating the respiratory ailment; At the current pace of vaccination against coronavirus, India would need another 8 years and 9 months to inoculate 70 per cent of its entire population, a threshold required to achieve herd immunity. Watch this and more news on News Blast. Read | COVID-19: Tips from psychologists to cope in these uncertain times Also Read | AUMs of Indian Mutual Fund industry decreases 0.5% m-o-m

UP NEXT

UP NEXT

image beaconimage beaconimage beacon